[Domestic exposure to moulds and mite allergens in Parisian patients]

E Dalibert1, M Dusséaux1, V Bex1

  • 1Service parisien de santé environnementale, 11, rue George-Eastman, 75013 Paris, France.

Abstract

Insights

Indoor mould and mite allergens can impact respiratory health. This study found higher levels of both in Parisian homes, especially when ventilation is poor or mould is visible.

Area of Science:

  • Environmental Health
  • Indoor Air Quality
  • Allergen Exposure

Background:

  • Indoor moulds and mite allergens are significant contributors to respiratory health issues.
  • Previous research highlights the link between indoor allergens and adverse health outcomes.

Purpose of the Study:

  • To assess the levels of fungal and mite allergen contamination in Parisian dwellings.
  • To investigate the relationship between environmental factors and allergen presence.

Main Methods:

  • Investigations conducted in 293 dwellings from 2011-2015 by the Paris Service for Environmental Health (SPSE).
  • Included fungal analysis of air, mattress, and floor dust.
  • Quantified mite allergens (Der p1) in mattresses and carpets.

Main Results:

  • Indoor air fungal concentrations were similar to outdoor levels, but increased with poor ventilation.
  • Mattress fungal contamination correlated with visible surface moulds.
  • Higher Der p1 mite allergen levels were found in mattress dust where mould contamination was visible.

Conclusions:

  • This study provides data on indoor contamination levels in Parisian patient homes.
  • Findings suggest a correlation between visible mould, poor ventilation, and increased allergen levels.

Related Concept Videos

Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
268
Allergic Reactions02:06

Allergic Reactions

Overview
32.4K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
239
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266